Arena Pharma (ARNA) Misses Q3 EPS by 19c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Loss from operations: -9.86M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from operations: -9.86M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.86), $0.19 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $5.48 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
